Additionally, Tg2576, a transgenic animal model of AD, displayed high premature fatality upon Ccr2 deficiency, which further implies that Ccr2-dependent microglial Aβ clearance may exert neuroprotective effects in early AD. This evidence concerns the gene CCR2 and Alzheimer disease.